Launch
Website- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Dr Dionysis Papadatos-Pastos is a London-based consultant oncologist specialising in the treatment of lung cancer, mesothelioma, thymic tumours, and other thoracic cancers. Recognised as one of the leading private oncologists in London, he combines medical excellence with a compassionate, patient-centred approach to care.
With a strong belief that every patient deserves both advanced science and humanity in equal measure, Dr Papadatos-Pastos supports individuals and their families through every step of the cancer journey � from diagnosis and treatment to long-term wellbeing.
Professional Background and Expertise
Dr Papadatos-Pastos serves as Lead for Lung Cancer at the CRUK UCL Clinical Trials Centre and Co-Chair of The London Clinic Lung Cancer Multidisciplinary Team (MDT).
In these roles, he leads collaborative teams of thoracic surgeons, respiratory physicians and radiologists, to design personalised treatment plans for each patient.
His clinical expertise includes immunotherapy, targeted therapy, and chemotherapy, with a focus on providing access to the most innovative and effective treatment strategies available in modern oncology.
Dr Papadatos-Pastos graduated in Medicine with distinction from the University of Athens, later earning a PhD in Medical Oncology (First Class Honours).
He completed advanced clinical training at leading UK cancer institutions, including The Royal Marsden Hospital, where he held a Clinical Fellowship at the world-renowned Drug Development Unit. During this period, he contributed to the early development of new cancer drugs, pioneering research in targeted therapies and immunotherapy combinations.
He also holds a Diploma in Medical Oncology from the Institute of Cancer Research, University of London.
Research and Clinical Trials
As an active clinical researcher, Dr Papadatos-Pastos has served as Principal Investigator on numerous academic and commercial clinical trials. His research focuses on non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and mesothelioma, aiming to expand access to new treatments and improve outcomes for patients worldwide.
His work has been published in international peer-reviewed journals, and he regularly presents at major oncology conferences in the UK and abroad, sharing advancements in thoracic cancer treatment.
Areas of interest
Lung Cancer, Mesothelioma, Thymic Cancer, Thymoma
Medical secretaries
- Mori Heydari and Susanne Proudfoot
- The London Clinic 146 Harley Street London W1G 7JZ
- 020 7616 7667
- enquiries@oncologist.london
Papadatos-Pastos, place of work 
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (>50)
The London Clinic (>50) HCA Healthcare UK Leaders in Oncology Care (1-5)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
The London Clinic (5-50) HCA Healthcare UK Leaders in Oncology Care (5-50)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)
The London Clinic (5-50) HCA Healthcare UK Leaders in Oncology Care (5-50)
-
20365
Follow-up out-patient consultation - remote - (5-50)
-
X0001
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 0-7 days - (1-5)
The London Clinic (1-5) HCA Healthcare UK Leaders in Oncology Care (1-5)
- Show All (6 )...